Posted in | News | Nanobusiness

The Who's Who of Micro-Nano Technology to Converge at COMS 2011 in August

The annual Commercialization of Micro-Nano Systems Conference (COMS 2011) being held Aug 28-31 in Greensboro, is again shaping up to be a who's who of the micro-nano technology (MNT) community, bringing together leaders in North Carolina with those from around the globe. Plenary Speakers include: Anthony Atala, MD, Joseph M. DeSimone, PhD and Paul M. Zavracky, PhD.

Dr. Atala is the W.H. Boyce Professor, Director of the Institute for Regenerative Medicine, and Chair of the Department of Urology at Wake Forest University. Dr. Atala is a practicing surgeon and a key thought leader in regenerative medicine. His current breakthroughs include the world's first engineered urethras using 3D printers to engineer human kidneys in a laboratory, and he is currently working to launch the Virginia Tech/Wake Forest Center for Veterinary Regenerative Medicine.

Dr. DeSimone is the Chancellor's Eminent Professor of Chemistry, University of North Carolina at Chapel Hill, and William R. Kenan, Jr. Distinguished Professor of Chemical Engineering, North Carolina State University. DeSimone is also an adjunct member at Memorial Sloan-Kettering Cancer Center. His research group is focused on nanofabrication techniques translated from the semiconductor industry that enables the manufacture of highly uniform nanoparticles with precise size and shape. This process, called Particle Replication in Non-Wetting Templates (PRINT), is currently being commercialized for biomedical applications through the spin-out company Liquidia Technologies, which has a PRINT-enabled flu vaccine therapeutic in clinical development.

Dr. Zavracky, President of North American and European Operations at MEMSIC Corporation, has more than 30 years of business, scientific and academic experience, serving most recently as Dean of Northeastern University's School of Technological Entrepreneurship. Prior to that, he co-founded The MicroOptical Corporation and, while serving as president and COO, developed two-axis MEMS micro-mirrors and successfully launched the company's military, medical and consumer head-mounted display businesses. Earlier in his career, he was a member of the founding team and COO of Kopin Corporation, where he spearheaded its development of silicon on insulator (SOI) materials and SOI MEMS devices.

Demonstrating the support for these important emerging technologies, James Hunt, Governor of North Carolina (1977-1985; 1993-2001) and Kay R. Hagan, United States Senator for North Carolina, will deliver keynote addresses. Also speaking is Sally Tinkle, PhD, Acting Director, National Nanotechnology Coordination Office, Nanoscale Science, Engineering, and Technology Subcommittee, Committee on Technology National Science and Technology Council. The NNI brings together the expertise needed to advance this broad and complex field - creating a framework for shared goals, priorities, and strategies that help each participating Federal agency leverage the resources of all participating agencies. With the support of the NNI, nanotechnology R&D is taking place in academic, government, and industry laboratories across the United States. MANCEF is not only proud to welcome these distinguished members of the policy making bodies to COMS, but also welcomes members of the triple helix; Education, Government and Industry, to join us in leading the next revolution of emerging technologies.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.